Stock Events

Stock Events

RetinalGenix Technologies 

$3.99
4
-$0.01-0.25%Friday 20:00

Statistics

Day High
4
Day Low
4
52W High
4
52W Low
3.2
Volume
18
Avg. Volume
10
Mkt Cap
75.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-2.43MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
NovoCure
NVCR
Mkt Cap1.74B
NovoCure operates in the field of oncology and medical devices, similar to RetinalGenix's focus on innovative healthcare solutions.
Intuitive Surgical
ISRG
Mkt Cap138.47B
Intuitive Surgical develops, manufactures, and markets robotic products which compete in the medical device sector like RetinalGenix.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a major player in medical devices, directly competing with RetinalGenix in the healthcare equipment sector.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers medical devices and healthcare solutions, competing in similar markets as RetinalGenix.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific is involved in the development of medical devices, which places them in direct competition with RetinalGenix.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation specializes in medical technologies, including devices and equipment that compete with RetinalGenix's offerings.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet Holdings operates in the musculoskeletal healthcare sector, competing with RetinalGenix in the broader medical device market.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson's medical device segment competes with RetinalGenix in providing comprehensive healthcare solutions.

About

RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Show More
CEO
Jerry Katzman
Country
United States
ISIN
US76133Y1055

Listings

OTC Link
US
RTGN

0 Comments

Share your thoughts

FAQs

What is RetinalGenix Technologies stock price today?▼
The current price of RTGN is $3.99 USD — it has decreased by -0.25% in the past 24 hours. Watch RetinalGenix Technologies stock price performance more closely on the chart.
What is RetinalGenix Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange RetinalGenix Technologies stocks are traded under the ticker RTGN.
Is RetinalGenix Technologies stock price growing?▼
RTGN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year RetinalGenix Technologies has showed a +12.39% increase.
What is RetinalGenix Technologies market cap?▼
Today RetinalGenix Technologies has the market capitalization of 75.19M
What is RetinalGenix Technologies revenue for the last year?▼
RetinalGenix Technologies revenue for the last year amounts to 0 USD.
What is RetinalGenix Technologies net income for the last year?▼
RTGN net income for the last year is -2.43M USD.
In which sector is RetinalGenix Technologies located?▼
RetinalGenix Technologies operates in the Health & Wellness sector.
When did RetinalGenix Technologies complete a stock split?▼
The last stock split for RetinalGenix Technologies was on June 16, 2015 with a ratio of 1:2.5.
Where is RetinalGenix Technologies headquartered?▼
RetinalGenix Technologies is headquartered in Apollo Beach, United States.